GeneMedicine is developing next-generation viral immunotherapies to treat patients with refractory cancers. By utilizing engineered oncolytic viruses, the company aims to enhance immune responses against tumors, improving patient outcomes and quality of life.

Intocell develops antibody-drug conjugate (ADC) platform technologies that enhance targeted cancer therapies by linking potent cytotoxic agents to specific antibodies. This approach aims to improve treatment efficacy while minimizing off-target effects, addressing the limitations of traditional chemotherapy.

The startup offers a conversational platform that utilizes an AI-enabled bot to create structured message flows through a user-friendly drag-and-drop interface. This technology automates customer service interactions, allowing businesses to efficiently address customer queries and enhance satisfaction.

Solivis develops sulfide solid electrolytes for all-solid-state batteries, which enhance safety and energy density compared to traditional lithium-ion batteries. Their technology addresses the risks of liquid electrolytes, providing superior ionic conductivity across a wide temperature range.

The startup manufactures specialized equipment for the heating equipment industry, providing battery cathode and composite anode materials that enhance energy efficiency. Their solutions enable businesses to significantly lower carbon emissions while optimizing space utilization in their operations.

The startup operates an AI-based platform that utilizes a hyper-personalization algorithm and AI voucher support to enhance collaboration among businesses. This technology enables companies to optimize their marketing efforts without the need for human intervention, improving efficiency and effectiveness in customer engagement.